Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Alterations in Muscle Tone lll01:11

Alterations in Muscle Tone lll

Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association of matrix metalloproteinase-10 levels and genetic variant rs17860955 with severe vascular complications in patients with type 1 diabetes: prospective cohort.

Journal of diabetes and its complications·2025
Same author

Longitudinal changes in Mediterranean diet and transition between different obesity phenotypes.

Clinical nutrition (Edinburgh, Scotland)·2019
Same author

[Incidence of type 1 diabetes in Navarre (2009-2016): higher in the southern regions of the autonomous community].

Anales del sistema sanitario de Navarra·2018
Same author

Sex and age differences in the achievement of control targets in patients with type 2 diabetes: results from a population-based study in a South European region.

BMC family practice·2016
Same author

Acute exercise leads to increased HbA1c and fructosamine levels in athletes with type 1 diabetes.

The Journal of sports medicine and physical fitness·2015
Same author

[Incidence of type 1 diabetes in Navarre, 2009-2012].

Anales del sistema sanitario de Navarra·2014

Related Experiment Video

Updated: Jul 11, 2026

Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells
09:39

Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells

Published on: July 29, 2016

[Glucocorticoid hypofunction in myotonic dystrophy].

L Forga1, E Anda, F J Basterra

  • 1Servicio de Endocrinología, Hospital de Navarra, Pamplona. lforgall@cfnavarra.es

Anales Del Sistema Sanitario De Navarra
|September 28, 2007
PubMed
Summary

Myotonic dystrophy patients exhibit adrenal hypofunction, contrary to previous findings suggesting hyperactivity. This indicates a potential issue with ACTH receptor efficacy linked to the DMPK gene defect.

More Related Videos

Myo-mechanical Analysis of Isolated Skeletal Muscle
08:42

Myo-mechanical Analysis of Isolated Skeletal Muscle

Published on: February 22, 2011

Related Experiment Videos

Last Updated: Jul 11, 2026

Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells
09:39

Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells

Published on: July 29, 2016

Myo-mechanical Analysis of Isolated Skeletal Muscle
08:42

Myo-mechanical Analysis of Isolated Skeletal Muscle

Published on: February 22, 2011

Area of Science:

  • Endocrinology
  • Genetics
  • Molecular Biology

Context:

  • Myotonic dystrophy (DM1) is a genetic disorder caused by CTG repeat expansion in the DMPK gene.
  • DM1 is a multi-systemic disease with known endocrine implications.
  • Previous studies suggested hypothalamic-pituitary-adrenal (HPA) axis hyperactivity in DM1.

Purpose:

  • To investigate adrenal function in patients with myotonic dystrophy.
  • To compare adrenal hormone levels and responses between DM1 patients and healthy controls.
  • To explore the relationship between CTG repeat expansion and adrenal function.

Summary:

  • This study analyzed 25 DM1 patients and 25 controls, assessing basal cortisol and ACTH, and responses to ACTH and CRH stimulation.
  • Results showed DM1 patients had lower basal cortisol and blunted cortisol response to CRH, with elevated ACTH, suggesting adrenal hypofunction.
  • One patient presented with primary adrenal failure; others showed no basal ACTH differences but impaired cortisol response.

Impact:

  • Findings challenge the notion of HPA axis hyperactivity in DM1, proposing adrenal hypofunction instead.
  • Suggests a potential defect in ACTH receptor efficacy or post-receptor signaling in DM1 patients.
  • The etiology may be linked to the genetic defect in the DMPK gene, impacting adrenal function.